Reuters logo
BRIEF-Orphomed secures $39 mln series A financing round
May 24, 2017 / 11:12 AM / 5 months ago

BRIEF-Orphomed secures $39 mln series A financing round

May 24 (Reuters) -

* Orphomed secures $39 million series A financing round

* Orphomed says capital will be used to advance clinical development of its lead candidate, ORP-101, for treatment of IBS-diarrhea Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below